Gastrointestinal Stents Market Five Years Forecast Skeleton With Key Companies Cook Medical, Ella-CS, Endo-Flex, Diagmed Healthcare, Micro-Tech

Market players are focusing on inorganic strategies such as mergers, acquisitions, or collaborations to increase their foothold in the market. For instance, in May 2018, Olympus— a company that designs and delivers innovative solutions for medical and surgical procedures—entered into an agreement with M.I. Tech, a company that designs stents and other devices. Under this agreement, HANAROSTENT, biliary and esophagus stents rolled in the EndoTherapy product portfolio of the company. The displacement of the stents is a major issue faced after the stent is been placed. Targeting these issues, in 2017, W. L. Gore & Associates, the manufacturer of Gore Viabil short wire biliary endoprosthesis stent, launched anti-migration assurance program, under which device will be replaced within a period of one year if it migrates.

Growth of the global gastrointestinal stents market is expected to be fuelled by increasing product launches with novel technology by key players in the market. For instance, in 2013, Cook Medical Inc. received U.S. Food and Drug Administration (FDA) for biliary stent, adding to the line of controlled-release gastrointestinal tract. Moreover, Evolution biliary stent incorporates patency design, to prevent migration of stent after its insertion. Furthermore, in 2012, Boston Scientific Corporation launched WallFlex, biliary Transhepatic Stent System for the treatment of benign biliary strictures.

Get HOLISTIC Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1756

Companies are focusing on manufacturing stents with biodegradable material to eliminate stent removal procedures. However, implantable products are subjected to stringent regulations, and this is expected to hinder growth of the gastrointestinal stent market. Moreover, complication associated with gastrointestinal stent implantation is also expected to be major factor leading to low adoption of these device.

Increasing prevalence of urological and gastrointestinal disorders are propelling demand of gastrointestinal stents during the forecast period. According to Center for Disease Control and Prevention (CDC), in 2015, number of adults diagnosed in U.S. with ulcer in digestive tract are 14.7 million, comprising 6% of the total adult population. Moreover, according to American Cancer Society’s estimation for year 2018 suggests that 9,220 new cases of colon cancer are expected to be diagnosed in the U.S. Moreover, increasing number of patients with gastrointestinal tumors is also adding to patient pool that can be subjected to gastrointestinal stent implantation.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1756

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.